Neck masses differential diagnosis: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Ssharfaei (talk | contribs)
editnews, nocaptcha, Administrators, Widget editors
7,502 edits
Ssharfaei (talk | contribs)
editnews, nocaptcha, Administrators, Widget editors
7,502 edits
Line 8: Line 8:
Differential diagnosis of neck masses include:
Differential diagnosis of neck masses include:
{|
{|
! rowspan="3" |Category
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
!
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
Line 17: Line 19:
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|-
|-
!
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
Line 25: Line 28:
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
|-
|-
!
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
Line 33: Line 37:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Others
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Others
|-
|-
! align="center" style="background:#DCDCDC;" |
!Congenital
! align="center" style="background:#DCDCDC;" |'''Branchial cleft cyst'''
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 52: Line 58:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! align="center" style="background:#DCDCDC;" |
!
! align="center" style="background:#DCDCDC;" |'''Thyroglossal duct cyst'''
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 71: Line 79:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! align="center" style="background:#DCDCDC;" |
!
! align="center" style="background:#DCDCDC;" |'''Hemangioma'''
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 90: Line 100:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! align="center" style="background:#DCDCDC;" |
!
! align="center" style="background:#DCDCDC;" |Vascular malformations
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 109: Line 121:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! align="center" style="background:#DCDCDC;" |
!
! align="center" style="background:#DCDCDC;" |Lymphatic malformations
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 128: Line 142:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! align="center" style="background:#DCDCDC;" |
!
! align="center" style="background:#DCDCDC;" |'''Laryngocele'''
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 147: Line 163:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! align="center" style="background:#DCDCDC;" |
!
! align="center" style="background:#DCDCDC;" |'''Ranula'''
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 166: Line 184:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
!'''Teratoma'''
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
!
!'''Dermoid cyst'''
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
!
!'''Thymic cyst'''
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
!Category
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
!
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
Line 185: Line 268:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|-
|-
! align="center" style="background:#DCDCDC;" |
!Inflammatory
! align="center" style="background:#DCDCDC;" |'''Reactive viral lymphadenopathy'''
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 204: Line 289:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! align="center" style="background:#DCDCDC;" |
!
! align="center" style="background:#DCDCDC;" |'''Bacterial lymphadenopathy'''
!Tularemia
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 223: Line 310:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
! align="center" style="background:#DCDCDC;" |
!Brucellosis
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 242: Line 331:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
! align="center" style="background:#DCDCDC;" |
!Cat-scratch disease
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 261: Line 352:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
! align="center" style="background:#DCDCDC;" |
!Actinomycosis
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 280: Line 373:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
! align="center" style="background:#DCDCDC;" |
!Mycobacterial infections
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 299: Line 394:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
! align="center" style="background:#DCDCDC;" |
!HIV
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 318: Line 415:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! align="center" style="background:#DCDCDC;" |
!
! align="center" style="background:#DCDCDC;" |'''Parasitic lymphadenopathy'''
!Toxoplasma gondii
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 337: Line 436:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! align="center" style="background:#DCDCDC;" |
!
! align="center" style="background:#DCDCDC;" |Sarcoidosis
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 356: Line 457:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! align="center" style="background:#DCDCDC;" |
!
! align="center" style="background:#DCDCDC;" |Castleman disease
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 375: Line 478:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! align="center" style="background:#DCDCDC;" |
!
! align="center" style="background:#DCDCDC;" |Rosai-Dorfman disease
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 394: Line 499:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
!Kawasaki disease
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
!Category
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
!
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
Line 413: Line 541:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|-
|-
! align="center" style="background:#DCDCDC;" |
!Neoplasm
! align="center" style="background:#DCDCDC;" |'''primary thyroid tumor'''
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 432: Line 562:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! align="center" style="background:#DCDCDC;" |
!
! align="center" style="background:#DCDCDC;" |'''Benign salivary gland neoplasm'''
!pleomorphic adenoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 451: Line 583:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
! align="center" style="background:#DCDCDC;" |
!Warthin's tumor
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 470: Line 604:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
! align="center" style="background:#DCDCDC;" |
!lymphoepithelioma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 489: Line 625:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! align="center" style="background:#DCDCDC;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!oncocytoma
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
!
!
|-
!
!
!monomorphic adenoma
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
!
!'''Malignant salivary gland neoplasm'''
!mucoepidermoid carcinoma
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
!
!
!adenoid cystic carcinoma
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
!
!
!adenocarcinoma
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
!
!
!salivary duct carcinoma
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
!
!
!squamous cell carcinoma
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
!
!'''Paraganglioma'''
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
!
!'''Schwannoma'''
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
!
!'''Lymphoma'''
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
|-
! align="center" style="background:#DCDCDC;" |
!
| align="center" style="background:#F5F5F5;" |
!'''Lipoma'''
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
!
!
|-
|-
! align="center" style="background:#DCDCDC;" |
!
! align="center" style="background:#DCDCDC;" |'''Metastatic head and neck carcinoma'''
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 546: Line 877:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!Category
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
!
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign

Revision as of 17:28, 14 January 2019

Neck masses Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neck Masses from other Conditions

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neck masses differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Neck masses differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neck masses differential diagnosis

CDC on Neck masses differential diagnosis

Neck masses differential diagnosis in the news

Blogs on Neck masses differential diagnosis

Directions to Hospitals Treating Neck masses

Risk calculators and risk factors for Neck masses differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Differentiating neck masses from other Diseases

Differential diagnosis of neck masses include:

Category Diseases Etiology Benign Malignant Clinical manifestation Paraclinical findings Gold standard diagnosis Associated findings
Demography History Symptoms Signs Lab findings Histopathology Imaging
Mass Pain Dysphagia Mass exam Skin changes LAP Others
Congenital Branchial cleft cyst
Thyroglossal duct cyst
Hemangioma
Vascular malformations
Lymphatic malformations
Laryngocele
Ranula
Teratoma
Dermoid cyst
Thymic cyst
Category Diseases Etiology Benign Malignant Demography History Mass Pain Dysphagia Mass exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Inflammatory Reactive viral lymphadenopathy
Bacterial lymphadenopathy Tularemia
Brucellosis
Cat-scratch disease
Actinomycosis
Mycobacterial infections
HIV
Parasitic lymphadenopathy Toxoplasma gondii
Sarcoidosis
Castleman disease
Rosai-Dorfman disease
Kawasaki disease
Category Diseases Etiology Benign Malignant Demography History Mass Pain Dysphagia Mass exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Neoplasm primary thyroid tumor
Benign salivary gland neoplasm pleomorphic adenoma
Warthin's tumor
lymphoepithelioma
oncocytoma
monomorphic adenoma
Malignant salivary gland neoplasm mucoepidermoid carcinoma
adenoid cystic carcinoma
adenocarcinoma
salivary duct carcinoma
squamous cell carcinoma
Paraganglioma
Schwannoma
Lymphoma
Lipoma
Metastatic head and neck carcinoma
Category Diseases Etiology Benign Malignant Demography History Mass Pain Dysphagia Mass exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings

References

Retrieved from "https://www.wikidoc.org/index.php?title=Neck_masses_differential_diagnosis&oldid=1535555"